FR:OSE Stock Latest News
Company AnnouncementsOSE Immunotherapeutics Reports Capital and Voting Rights as of October 316d ago
Company AnnouncementsOSE Immunotherapeutics’ Tedopi Combo Shows Survival Gain in Lung Cancer Phase 2 Trial2w ago
Company AnnouncementsOSE Immunotherapeutics’ Tedopi Combo Shows Survival Gain in Phase 2 NSCLC Trial4w ago
Company AnnouncementsOSE Immunotherapeutics to Present at Chardan Healthcare Conference in New York1M ago
Company AnnouncementsOSE Immunotherapeutics Updates Share Capital and Voting Rights Structure1M ago
Company AnnouncementsOSE Immunotherapeutics Extends Cash Runway as Tedopi and Lusvertikimab Advance in Late-Stage Trials1M agoCompany AnnouncementsOSE Immunotherapeutics’ Tedopi Lung Cancer Trial Selected for Oral Presentation at ESMO 20261M ago
Company AnnouncementsOSE Immunotherapeutics’ Partner Veloxis Starts Phase 2 Trial of Transplant Drug Pegrizeprument2M ago
Company AnnouncementsOSE Immunotherapeutics Updates Share Capital and Voting Rights After New Share Issuance2M ago
Company AnnouncementsOSE Immunotherapeutics Showcases Lead IBD Drug Lusvertikimab in Upcoming KOL Webcast2M ago
Company AnnouncementsOSE Immunotherapeutics Updates Share Capital and Voting Rights After New Equity Issuance2M ago



